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1145-27 Is There Still a Role for Physician Assessment in the 
Emergency Department in the Era of Novel Cardiac 
Markers? 
Ali F, Sonel, Jeffrey Whittle, Mary Kelley, Robert L. Wilenskv. University of Pittsburgh and 
VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, University of Pennsylvania, 
Philadelphia, Pennsylvania. 
Elevated serum levels troponin I (Tnl), myosin light chain (MLC), and myoglobin (Mb) 
predict short term cardiac ischemic events in patients presenting to the Emergency 
Department (ED) with chest pain. The additive value of such markers with clinical 
assessment has not been assessed. In order to determine the additive predictive value of 
markers of myocardial injury with clinician judgement in predicting early ischemic events 
in patients presenting to the ED, we prospectively studied 247 patients presenting to 2 
EDs within 24 hours of the onset of symptoms consistent with an acute coronary artery 
syndrome. After initial assessment, physicians estimated the probability of a major 
adverse cardiac event (MACE), consisting of death, myocardial infarction or ischemia 
driven revascularization within the initial week based on their initial history, physical 
examination and electrocardiogram (ECG). Serum samples were obtained for Tnl, MLC, 
and Mb at presentation and in 4 hours, Physician decisions were made without the 
knowledge of the cardiac marker results. Mean age of the patient population was 52 ± 13 
years and 54% of subjects were male. During follow-up, 1% died, 13% suffered an acute 
myocardial infarction, and 15% underwent coronary revascutarization. Factors shown to 
predict events included ST-elevation (p<0.00Ol), QRS >120 msec (p=0.005), serial ECG 
changes (p=0.02), pathologic q-waves (p=0.05), an elevated serial Tnl (p=0.006) or 
serial MLC level (p=0.008) and the physician estimate of increased risk (p<0.0001). In 
the multivariable analysis, only ST segment elevation at presentation, a QRS duration 
>120 msec, an elevated MLC and physician prediction of likelihood of cardiac events 
were independent predictors of MACE. A decision rule based solely on physician esti- 
mated probability of MACE and ECG findings had 96% sensitivity and 33% specificity for 
predicting MACE and was not improved by the addition of marker data. Although new 
cardiac markers of myocardial damage provide important information on short-term out- 
come, physician assessment still remains the most important predictor. Hence, use of 
cardiac markers should only be used in conjunction with physician assessment of cardiac 
risk. 
1145-28 Validation of a Simple Electrocardiographic Criterion for 
Early Risk Assessment In Patients With Non-ST 
Segment Elevation Acute Myocardial Infarction 
Jose A. Barrabes, Jaume Figueras, Josefa Cortadellas, Sonia Ibars, Jordi Soler-Soler, 
Hospital Universitad Vail d'Hebren, Barcelona, Spain. 
Background: The prognostic significance of the location of ST segment depression in 
patients with non-ST elevation acute myocardial infarction (AMI) is controversial. We 
aimed to confirm the previous observation that _>0.1 mV ST segment depression in >2 of 
the lateral leads I, aVL, V 5 and V 6 (STD_L) predicts a worse in-hospital outcome. 
Methods; We analyzed 343 consecutive patients admitted to our center between 1996 
and 1999 with a first AMI without Q waves or >0.1 mV ST segment elevation on admis- 
sion. 
Result: STD_L was the only variable from the initial ECG that was related to death after 
adjusting for baseline predictors (odds ratio: 5.3, 95% CI: 1.4 to 20.9, P<0.01), and was 
consistentl 7 associated with other adverse events: 
Event rate (%) No STD STD, non- STD_L 
(n=147) lateral (n=82) (n= 114) 
Death 1.4 1.2 14.9 
Reinfarction 0,7 1.2 11.4 
Angina with ST 10.2 9.8 29.8 
changes 
Severe heart failure 2.0 3.7 32.5 
Patients with STD_L had a similar CK-MB peak than the rest (116±12 vs. 134±10 mcg/I, 
respectively, P=NS). However, among the 176 patients that were catheterized before dis- 
charge, those with STD_L had lower left ventricular ejection fraction (61±2 vs. 68+1%, 
P=0.01) and more frequent left main or three-vessel disease than did the remaining 
patients (56 vs. 23%, P<0.001). Percutaneous intervention was carried out in 24 and 
23% of patients with and without STD_L (P=NS), and surgical revascularization was indi- 
cated in 20 and 7%, respectively (P=0.001). 
Conclusion: In patients with a first non-ST segment elevation acute MI, STDL on 
admission is a simple and efficient criterion for early risk assessment, and its presence is 
related to extensive coronary artery disease. 
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1145-29 Value of Continuous Risk Stratification Early After 
Admlseion in Non-ST-Segment Elevation Acute 
Coronary Syndromes 
Joroe M. Ferraira. Carlos Aguiar, Ana Timdteo, Katya Reis Santos, Ricardo Seabra- 
Gomes, Department of Cardiology, Hospita/ de Santa Cruz, Camaxide, Portugal 
Background: Patients (P) with non-ST-segment elevation acute coronary syndromes 
(ACS) present a wide range of risk of death (D) or (re)-infarction (MI). As a great number 
of these events occur soon during evolution, early risk stratification is imperative. Never- 
theless, after risk stratification at admission, the majority of P fall within a wide grey zone 
of intermediate risk. We sought to identity clinical variables and diagnostic methods pre- 
dictive of D/MI at 30 days, in P classified initially as intermediate risk according to the 
TIMI Risk Score. 
Methods: We studied 254 consecutive P with ACB. TIMI Risk Score was calculated on 
admission, and the sub-groups of P with high and intermediate risk of D/MI at 30 days 
were identified using the best cut-offs for the Score. in the sub-group of intermediate risk, 
we evaluated the prognostic value of clinical variables and diagnostic methods per- 
formed during the first 24 hours and not used in the TIMI Risk Score. 
Results: The incidence of D/MI at 30 days was 93%. A TIMI Risk Score of 6 or 7 (19 P, 
31.6% D/MI) or Score 5 (47 P, 14.9% D/MI) identified only a small group of P at high risk 
for D/MI (p=0.004). The remaining 188 P were classified as intermediate risk: Score 4 (76 
P,  7.9% D/MI), Score 3 (62 P, 4.8% D/MI), Score 2 (35 P, 5.7% D/MI) and Score 0 or 1 
(15 P, 6.7% of D/MI). The presence in the first 24 hours, of signs of heart failure 
(p=0.001), ST-segment shifts > 0.1mV detected by continuous ST-segment monitoring 
(p=0.002) or left ventricular ejection fraction (LVEF)<50% (p=0.012) were predictive of D/ 
MI and identified 92% of these events. The absence of these findings was associated 
with the lowest risk (107 P, 0.9% D/MI) and the risk increased with the number of find- 
ings: 1 finding (53 P, 9.4% D/MI), 2 findings (24 P, 16.7% D/MI) and 3 findings (4 P, 50% 
D/MI). 
Conclusion: Risk stratification at admission using the TIMI Risk Score identified only a 
small group of P at high risk for D/MI at 30 days. In the remaining P at intermediate risk, 
the presence of signs of heart faiiura, ST-segment shifts by continuous ST-segment mon- 
itoring or LVEF<50% identified the majority of those with D/MI. 
1145-30 Abciximab Partially Attenuates Adverse Events 
Associated With Trombocytopenia: Analysis of GUSTO 
IV ACS 
Richard T. Williams. David C. Sane, Lakshmi V. Damaraju, Mary A. Mascelli, Elliot S, 
Barnathan, Robert M. Califf, Maarten Simoons, Wake Forest University/Baptist Medical 
Center, Winston-Salem, North Carolina, Duke Universi~ Durham, North Carolina. 
Background: The development of thrombocytopenia (TCP) in patients with acute coro- 
nary syndromes (ACS) is associated with higher rates of major adverse clinical events 
(MACE) including death, MI and hemorrhage. Although the association between TCP 
and hemorrhage is apparent, the increased risk of MI and death in this group requires 
"further study. The GUSTO IV - ACS trial was designed to assess the effects of abciximab 
on death or MI in non-ST segment elevation ACS patients without early intervention. 
There was no benefit with abciximab use and a trend toward increased MACE with 
longer infusion times in this setting. We hypothesized that prolonged infusions of abcix- 
imab might increase the occurrence of TCP and therefore lead to increased MACE. 
Methods: We examined the occurrence of TCP (platelet count < 100 X 109/L and a 25% 
decrease from baseline) and its effect on MACE in the GUSTO IV - ACS patient popula- 
tion. 
Results: The prevalence of TCP was 1.0 % in the placebo group, 4.7% in the 24 hour 
abciximab infusion group, and 7.0 % in the 48 hour abciximab infusion group (p= 0.001). 
The occurrence of adverse events in the three groups as a function of the presence or 
absence of TCP is tabulated below: 
PLACEBO 24 HR ABCIXIMAB 48 HR ABCIXIMAB 
TCP NOTCP p TCP NOTCP p TCP NOTCP p 
(n=26) (n=2572) (n=121) (n=2469) (n=184) (n=2428) 
Death or MI 26.9% 7.9% 0.003 10.7% 8.1% 0.306 12.5% 8.9% 0.110 
Death, MI or 53.8% 34.8% 0.061 33.1% 33.3% 1.000 35.9% 35.7% 1.000 
Revasc. 
Death 15.4% 3.8% 0.017 4.1% 3.4% 0.604 5.4% 4.2% 0.448 
MI 19.2% 5.0% 0.009 6.6% 5.6% 0.548 9.2% 5.6% 0.050 
Conclusion: TCP is associated with increased MACE in the placebo group, but this 
effect is blunted in the abciximab-treated groups. Although abciximab causes a higher 
rate of TCP, it also lessens the adverse events associated with TCP. The clinical signifi- 
cance and mechanism of these findings warrant further investigation. 
1145-45 Underuse of Evidence-Based Medicine and Outcome of 
Acute Myocardial infarction Patients With Renal Failure 
Ariel Tessone, Israel M. Barbash, Shmuel Gottlieb, Alexander Battler, Yonathan Hasin, 
Valentina Boyko, Avi Porat, Solomon Behar, Jonathan Leor, Neufe/d Cardiac Research 
Institute, TeI-Hashomer, Israel. 
To evaluate the impact of renal failure upon management and outcome of MI patients we 
analyzed data of 1683 consecutive patients with acute MI admitted to 26 hospitals in 
Israel during a 2 month (2-3/2000) peded. We compared clinical characteristics, manage- 
ment and outcome between 132 patients with renal failure (creatinine >1.3 mg/dl) vs. 
1551 without (control) (Table). MI pts with CRF were more likely to die within 30d 
(OR=3.1 ; 95% CI 2.0-4.8 ). After adjustment for age and COomorbidities this association 
declined (OR=1,5; 95% CI 0.9-2.5 ). Adding thrombolysis and PCI into the statistical 
model did not affect the association between CRF and mortality. However, addition of 
